Novavax, Inc. (NVAX)
9.505
-0.60
(-5.98%)
USD |
NASDAQ |
Mar 03, 16:00
9.50
0.00 (0.00%)
After-Hours: 18:22
Novavax Shareholders Equity (Quarterly) : -127.75M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Merck & Co., Inc. | 52.61B |
| Pfizer Inc. | 86.48B |
| Moderna, Inc. | 8.65B |
| Intellia Therapeutics, Inc. | 671.39M |
| Recursion Pharmaceuticals, Inc. | 1.131B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.183B |
| Total Liabilities (Quarterly) | 1.311B |
| Debt to Equity Ratio | -2.176 |
| Current Ratio | 2.127 |
| Net Debt Paydown Yield | -0.82% |